A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00931840
Recruitment Status : Unknown
Verified September 2011 by Enzon Pharmaceuticals, Inc..
Recruitment status was:  Active, not recruiting
First Posted : July 2, 2009
Last Update Posted : September 20, 2011
Information provided by (Responsible Party):
Enzon Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : October 2011
  Estimated Study Completion Date : January 2012